377 related articles for article (PubMed ID: 34948322)
1. Regulation of p53 and Cancer Signaling by Heat Shock Protein 40/J-Domain Protein Family Members.
Kaida A; Iwakuma T
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948322
[TBL] [Abstract][Full Text] [Related]
2. Identification of a druggable protein-protein interaction site between mutant p53 and its stabilizing chaperone DNAJA1.
Tong X; Xu D; Mishra RK; Jones RD; Sun L; Schiltz GE; Liao J; Yang GY
J Biol Chem; 2021; 296():100098. PubMed ID: 33208462
[TBL] [Abstract][Full Text] [Related]
3. Mutant p53 Depletion by Novel Inhibitors for HSP40/J-Domain Proteins Derived from the Natural Compound Plumbagin.
Alalem M; Bhosale M; Ranjan A; Yamamoto S; Kaida A; Nishikawa S; Parrales A; Farooki S; Anant S; Padhye S; Iwakuma T
Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077724
[TBL] [Abstract][Full Text] [Related]
4. DNAJA1 promotes cancer metastasis through interaction with mutant p53.
Kaida A; Yamamoto S; Parrales A; Young ED; Ranjan A; Alalem MA; Morita KI; Oikawa Y; Harada H; Ikeda T; Thomas SM; Diaz FJ; Iwakuma T
Oncogene; 2021 Aug; 40(31):5013-5025. PubMed ID: 34183772
[TBL] [Abstract][Full Text] [Related]
5. DNAJA1 controls the fate of misfolded mutant p53 through the mevalonate pathway.
Parrales A; Ranjan A; Iyer SV; Padhye S; Weir SJ; Roy A; Iwakuma T
Nat Cell Biol; 2016 Nov; 18(11):1233-1243. PubMed ID: 27775703
[TBL] [Abstract][Full Text] [Related]
6. Gain-of-function mutant p53 in cancer progression and therapy.
Zhang C; Liu J; Xu D; Zhang T; Hu W; Feng Z
J Mol Cell Biol; 2020 Sep; 12(9):674-687. PubMed ID: 32722796
[TBL] [Abstract][Full Text] [Related]
7. Regulators of Oncogenic Mutant TP53 Gain of Function.
Yamamoto S; Iwakuma T
Cancers (Basel); 2018 Dec; 11(1):. PubMed ID: 30577483
[TBL] [Abstract][Full Text] [Related]
8. DNAJA1- and conformational mutant p53-dependent inhibition of cancer cell migration by a novel compound identified through a virtual screen.
Nishikawa S; Kaida A; Parrales A; Ranjan A; Alalem M; Ren H; Schoenen FJ; Johnson DK; Iwakuma T
Cell Death Discov; 2022 Oct; 8(1):437. PubMed ID: 36316326
[TBL] [Abstract][Full Text] [Related]
9. HSP40 proteins use class-specific regulation to drive HSP70 functional diversity.
Faust O; Abayev-Avraham M; Wentink AS; Maurer M; Nillegoda NB; London N; Bukau B; Rosenzweig R
Nature; 2020 Nov; 587(7834):489-494. PubMed ID: 33177718
[TBL] [Abstract][Full Text] [Related]
10. Allele-specific silencing of mutant p53 attenuates dominant-negative and gain-of-function activities.
Iyer SV; Parrales A; Begani P; Narkar A; Adhikari AS; Martinez LA; Iwakuma T
Oncotarget; 2016 Feb; 7(5):5401-15. PubMed ID: 26700961
[TBL] [Abstract][Full Text] [Related]
11. Pontin, a new mutant p53-binding protein, promotes gain-of-function of mutant p53.
Zhao Y; Zhang C; Yue X; Li X; Liu J; Yu H; Belyi VA; Yang Q; Feng Z; Hu W
Cell Death Differ; 2015 Nov; 22(11):1824-36. PubMed ID: 25857266
[TBL] [Abstract][Full Text] [Related]
12. Co-chaperones Bag-1, Hop and Hsp40 regulate Hsc70 and Hsp90 interactions with wild-type or mutant p53.
King FW; Wawrzynow A; Höhfeld J; Zylicz M
EMBO J; 2001 Nov; 20(22):6297-305. PubMed ID: 11707401
[TBL] [Abstract][Full Text] [Related]
13. J-domain protein chaperone circuits in proteostasis and disease.
Zhang R; Malinverni D; Cyr DM; Rios PL; Nillegoda NB
Trends Cell Biol; 2023 Jan; 33(1):30-47. PubMed ID: 35729039
[TBL] [Abstract][Full Text] [Related]
14. Gain of function mutant p53 protein activates AKT through the Rac1 signaling to promote tumorigenesis.
Yue X; Wu F; Li Y; Liu J; Boateng M; Mandava K; Zhang C; Feng Z; Gao J; Hu W
Cell Cycle; 2020 Jun; 19(11):1338-1351. PubMed ID: 32275841
[TBL] [Abstract][Full Text] [Related]
15. Class-specific interactions between Sis1 J-domain protein and Hsp70 chaperone potentiate disaggregation of misfolded proteins.
Wyszkowski H; Janta A; Sztangierska W; Obuchowski I; Chamera T; Kłosowska A; Liberek K
Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34873058
[TBL] [Abstract][Full Text] [Related]
16. Binding of a small molecule at a protein-protein interface regulates the chaperone activity of hsp70-hsp40.
Wisén S; Bertelsen EB; Thompson AD; Patury S; Ung P; Chang L; Evans CG; Walter GM; Wipf P; Carlson HA; Brodsky JL; Zuiderweg ER; Gestwicki JE
ACS Chem Biol; 2010 Jun; 5(6):611-22. PubMed ID: 20481474
[TBL] [Abstract][Full Text] [Related]
17. Mutant p53 in Cancer: Accumulation, Gain-of-Function, and Therapy.
Yue X; Zhao Y; Xu Y; Zheng M; Feng Z; Hu W
J Mol Biol; 2017 Jun; 429(11):1595-1606. PubMed ID: 28390900
[TBL] [Abstract][Full Text] [Related]
18. A unique chaperoning mechanism in class A JDPs recognizes and stabilizes mutant p53.
Zoltsman G; Dang TL; Kuchersky M; Faust O; Silva MS; Ilani T; Wentink AS; Bukau B; Rosenzweig R
Mol Cell; 2024 Apr; 84(8):1512-1526.e9. PubMed ID: 38508184
[TBL] [Abstract][Full Text] [Related]
19. The interplay between mutant p53 and the mevalonate pathway.
Parrales A; Thoenen E; Iwakuma T
Cell Death Differ; 2018 Mar; 25(3):460-470. PubMed ID: 29238070
[TBL] [Abstract][Full Text] [Related]
20. Specification of Hsp70 function by Type I and Type II Hsp40.
Cyr DM; Ramos CH
Subcell Biochem; 2015; 78():91-102. PubMed ID: 25487017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
